Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CODX |
---|---|---|
09:32 ET | 686 | 1.21 |
09:54 ET | 2000 | 1.28 |
10:06 ET | 469 | 1.26 |
10:12 ET | 274 | 1.2416 |
10:14 ET | 363 | 1.2596 |
10:17 ET | 349 | 1.24 |
10:28 ET | 200 | 1.24 |
10:33 ET | 100 | 1.23 |
10:57 ET | 100 | 1.23 |
11:04 ET | 2800 | 1.23 |
11:06 ET | 2500 | 1.22 |
11:11 ET | 100 | 1.23 |
11:15 ET | 100 | 1.24 |
11:26 ET | 5306 | 1.26 |
11:33 ET | 8338 | 1.26 |
11:36 ET | 4700 | 1.26 |
11:56 ET | 325 | 1.2455 |
12:07 ET | 100 | 1.26 |
12:18 ET | 200 | 1.2419 |
12:20 ET | 100 | 1.26 |
12:32 ET | 5003 | 1.26 |
12:43 ET | 100 | 1.28 |
12:59 ET | 7430 | 1.26 |
01:08 ET | 180 | 1.274 |
01:26 ET | 150 | 1.26 |
01:28 ET | 453 | 1.2699 |
01:33 ET | 200 | 1.25 |
01:37 ET | 200 | 1.25 |
01:50 ET | 100 | 1.26 |
01:55 ET | 5300 | 1.25 |
02:08 ET | 100 | 1.25 |
02:11 ET | 100 | 1.25 |
02:13 ET | 3955 | 1.25 |
02:22 ET | 200 | 1.2652 |
02:29 ET | 100 | 1.27 |
02:33 ET | 1000 | 1.26 |
02:36 ET | 200 | 1.27 |
02:44 ET | 500 | 1.26 |
03:00 ET | 100 | 1.27 |
03:09 ET | 100 | 1.27 |
03:18 ET | 3800 | 1.27 |
03:20 ET | 2997 | 1.2796 |
03:23 ET | 5356 | 1.2742 |
03:41 ET | 100 | 1.28 |
03:48 ET | 100 | 1.28 |
03:59 ET | 4998 | 1.28 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Co-Diagnostics Inc | 40.8M | -1.0x | --- |
T2 Biosystems Inc | 31.8M | -0.2x | --- |
Neuroone Medical Technologies Corp | 29.5M | -1.9x | --- |
Icecure Medical Ltd | 30.1M | -2.1x | --- |
Accelerate Diagnostics Inc | 46.2M | -0.9x | --- |
Medite Cancer Diagnostics Inc | 90.0 | 0.0x | --- |
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.8M |
---|---|
Revenue (TTM) | $9.1M |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.86 |
EPS | $-1.27 |
Book Value | $2.75 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 4.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -424.64% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.